Package 51316-007-67

{"route": ["ORAL"], "spl_id": "ca6c580e-a29b-4698-a226-bb8e3bdee26b", "openfda": {"unii": ["2S068B75ZU", "6V9V2RYJ8N"], "rxcui": ["997406"], "spl_set_id": ["e9161bb2-190f-14b3-e053-2995a90a9b2f"], "manufacturer_name": ["CVS Pharmacy, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 BLISTER PACK in 1 CARTON (51316-007-67)  / 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK", "package_ndc": "51316-007-67", "marketing_start_date": "20221117"}, {"sample": false, "description": "3 BLISTER PACK in 1 CARTON (51316-007-84)  / 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK", "package_ndc": "51316-007-84", "marketing_start_date": "20221117"}], "brand_name": "Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride", "product_id": "51316-007_ca6c580e-a29b-4698-a226-bb8e3bdee26b", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Adrenergic alpha-Agonists [MoA]", "Histamine H1 Receptor Antagonists [MoA]", "Histamine-1 Receptor Antagonist [EPC]", "alpha-Adrenergic Agonist [EPC]"], "product_ndc": "51316-007", "generic_name": "Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride", "labeler_name": "CVS Pharmacy, Inc.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride", "active_ingredients": [{"name": "FEXOFENADINE HYDROCHLORIDE", "strength": "60 mg/1"}, {"name": "PSEUDOEPHEDRINE HYDROCHLORIDE", "strength": "120 mg/1"}], "application_number": "ANDA209116", "marketing_category": "ANDA", "marketing_start_date": "20221117", "listing_expiration_date": "20261231"}